GLP-1 Clinical Trials for Alzheimers The ELAD Study: First Proof of Concept The first major human study tested liraglutide in 204 people with mild Alzheimers disease over one year
There is also an opportunity to reduce costs through collaboration
Liu J, Head E, Gharib AM, Yuan W, Ingersoll RT, Hagen TM, Cotman CW, Ames BN: Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid
However, it has also been reported that siRNA-mediated suppression of Acl mRNA by 80% did not affect GSIS in INS-1 cells [52]
Compound Heterozygotes (C677T + A1298C) Significantly reduced MTHFR function
Variants in GLP1R (rs6923761), FTO (rs9939609), and MC4R (rs17782313) can reveal whether your body may respond differently to GLP-1 therapy and how efficiently you manage oxidative stressinformation that should be interpreted with your qualified healthcare provider